Compliance and Audits - FAQ - Apexus 340B PVP

340B Compliance/Audits


340B Drug Pricing Program covered entities must ensure program integrity and maintain accurate records documenting compliance with all 340B Program requirements.

HRSA has the authority to audit covered entities for compliance with 340B Drug Pricing Program (340B Program) requirements (42 USC 256b(a)(5)(C)):

Covered entities are subject to audit by the manufacturer or the federal government. Failure to comply may make the 340B covered entity liable to manufacturers for refunds of discounts or cause the covered entity to be removed from the 340B Program.

HRSA posts   Audit Results on its website.

Top 5:

Click here to view all on this subject


Need Help?

Call Email